a month ago
ASML
AnalystsDavid DaiDavid Dai's Stock Forecasts
AnalystsDavid Dai
Analyst Ranking
Bottom 10%
#4763 out of 5263 analysts
Average Return
-2.16%
Win Rate
46%16 out of 35
Risk vs Reward
Poor
Good
David Dai's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Syndax Pharmaceuticals IncSNDX | +129.21% | $9.21 | $21.11 | 2025-07-14 - 2026-04-28 | Strong Buy |
Jdcom IncJD | +122.61% | $38.35 | $85.37 | 2020-03-16 - 2021-03-17 | Buy |
Perspective Therapeutics IncCATX | +89.00% | $2.09 | $3.95 | 2025-11-20 - 2026-04-28 | Strong Buy |
Merus NvMRUS | +80.02% | $52.30 | $94.15 | 2024-10-23 - 2025-09-30 | Strong Buy |
Cullinan Therapeutics IncCGEM | +61.95% | $7.91 | $12.81 | 2025-05-12 - 2026-04-28 | Strong Buy |
David Dai Analyst Color
Get additional color on David Dai's coverage of popular stocks
3 months ago
ASML
David Dai's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Janux Therapeutics IncJANX | 2 | Hold | $15.00 | +3.45% | Downgrades | 14 days ago |
Asml Holding NvASML | 3 | Buy | $1,971.00 | +42.36% | Maintains | a month ago |
Jasper Therapeutics IncJSPR | 1 | Hold | $1.50 | +61.29% | Assumes | a month ago |
Perspective Therapeutics IncCATX | 3 | Strong Buy | $8.00 | +102.53% | Maintains | a month ago |
Sony Group CorpSONY | 2 | Hold | $22.00 | +10.17% | Downgrades | a month ago |
Kura Oncology IncKURA | 4 | Strong Buy | $15.00 | +69.88% | Maintains | 2 months ago |
Iovance Biotherapeutics IncIOVA | 3 | Hold | $4.00 | +18.34% | Maintains | 2 months ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $128.00 | +52.65% | Maintains | 2 months ago |
Biontech SeBNTX | 1 | Hold | $117.00 | +14.64% | Maintains | 6 months ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $38.00 | +80.01% | Maintains | 6 months ago |
Nuvalent IncNUVL | 3 | Strong Buy | $132.00 | +29.49% | Maintains | 6 months ago |
Merus NvMRUS | 2 | Hold | $97.00 | +7.78% | Downgrades | 7 months ago |
Telix Pharmaceuticals LtdTLX | 1 | Strong Buy | $20.00 | +91.57% | Maintains | 7 months ago |
Nurix Therapeutics IncNRIX | 2 | Strong Buy | $26.00 | +52.22% | Maintains | 10 months ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $30.00 | +41.11% | Initiates Coverage On | 10 months ago |
Blueprint Medicines CorpBPMC | 2 | Hold | $129.00 | -0.36% | Maintains | a year ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $24.00 | +87.35% | Maintains | a year ago |
Immunocore Holdings PLCIMCR | 1 | Strong Sell | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Cg Oncology IncCGON | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 2 years ago |
Adicet Bio IncACET | 1 | Buy | $448.00 | N/A | Initiates Coverage On | 4 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 4 years ago |
Inhibrx IncINBX1 | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Macrogenics IncMGNX | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Nkarta IncNKTX | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Jdcom IncJD | 1 | Buy | $52.00 | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.